Definium Therapeutics' (DFTX) synthetic LSD eased the symptoms of anxiety, the company said Monday as shares, already up 190% this year, took off again. Patients showed a 9.8-point improvement on a 56-point Hamilton Anxiety Rating Scale 12 weeks after undergoing treatment. In comparison, the placebo group improved by 4.7 points.
The effect was rapid, with responses showing as early as…
Extract — continue reading at the source.
Related stories
This Surprising Stock Has Been Stanley Druckenmiller's No. 1 Position for 8 Straight Quarters. Is It a No-Brainer Buy?
S&P 500, Nasdaq fall on AI slowdown fears, oil price surge
Hain Celestial sells “international” assets to private-equity investor
Nike downgraded, Affirm upgraded: Wall Street's top analyst calls
Chip stocks fall as oil prices gain, Treasury yields stay elevated: AlphaCheck
Here’s how to prepare your portfolio for the Fed’s next interest-rate moves